Tommy� Fornander

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

Tommy� Fornander, Björn Cedermark, Anders Mattsson et al. · The Lancet · 1989 · 930 citations

Medicine, Oncology, Pharmacology +12

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.

DJ Slamon, W. Eiermann, Nicholas J. Robert et al. · Cancer Research · 2009 · 554 citations

Medicine, Oncology, Pharmacology +17

Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies

Lars Erik Rutqvist, Hemming Johansson, T. Signomklao et al. · JNCI Journal of the National Cancer Institute · 1995 · 510 citations

Medicine, Oncology, Pharmacotherapy +16

Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden

Paul McGale, Sarah C. Darby, Per Hall et al. · Radiotherapy and Oncology · 2011 · 462 citations

Medicine, Cardiology, Oncology +12